Shanghai Active Technology Raises Record RMB 330M Angel Round for Invasive BCI
Summary
Shanghai Active Technology, founded in February 2026, closed a RMB 330 million (about $45.7M) angel round, the largest angel financing yet in China's brain-computer interface sector. The round was led by Zhongke Chuangxing, with Lenovo Star, Daotong Investment, and several other investors participating. The company is pursuing full in-house development across flexible electrodes, dedicated chips, decoding algorithms, and system integration, and is simultaneously advancing three invasive BCI product lines targeting motor, vision, and emotion applications. Its motor-focused system, "Tian Shu," is a 1024-channel device aimed at stroke, spinal cord injury, and ALS patients, and is preparing to enter clinical trials.
Why it matters
A record-setting angel round for a company pursuing full vertical integration -- from custom chips to electrodes -- signals investor confidence that Chinese invasive BCI hardware is maturing toward clinical-grade manufacturing, not just prototype demonstrations.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial